Changeflow GovPing Pharma & Drug Safety Active Premix Aluminum Zirconium Salts Antipers...
Routine Rule Added Final

Active Premix Aluminum Zirconium Salts Antiperspirant

Favicon for changeflow.com USPTO Patent Applications - Pharma (A61K)
Published
Detected
Email

Summary

USPTO published patent application US20260096968A1 by Wade Charles Henke, Shawn David McConaughy, and David Frederick Swaile covering a particulate active premix composition containing an aluminum zirconium salt, an amino acid, and greater than 1% of an alkali metal salt for use in antiperspirant products.

What changed

USPTO published patent application US20260096968A1 filed by Henke et al. on October 3, 2025, covering a particulate active premix composition comprising aluminum zirconium salt, an amino acid, and greater than 1% by weight of an alkali metal salt, designed for incorporation into antiperspirant products. The application is classified under CPC codes A61K 8/28, A61K 8/20, A61Q 15/00, among others.

Personal care product manufacturers developing aluminum zirconium-based antiperspirant formulations should monitor this application for potential freedom-to-operate concerns. If granted, the patent would provide 20-year protection from the October 2025 filing date.

What to do next

  1. Monitor for patent grant status
  2. Review composition claims for potential infringement
  3. Update IP portfolio if competing compositions exist

Archived snapshot

Apr 9, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

ACTIVE PREMIX CONTAINING ALUMINUM ZIRCONIUM SALTS FOR ANTIPERSPIRANT PRODUCTS

Application US20260096968A1 Kind: A1 Apr 09, 2026

Inventors

Wade Charles HENKE, Shawn David MCCONAUGHY, David Frederick SWAILE

Abstract

A particulate active premix composition, and methods of making the premix composition. The premix composition includes an aluminum zirconium salt, an amino acid, and greater than 1% of an alkali metal salt. The composition can be a particle. The particulate active premix can be incorporated into antiperspirant products.

CPC Classifications

A61K 8/28 A61K 8/0241 A61K 8/20 A61K 8/44 A61Q 15/00 A61K 2800/412 A61K 2800/58 A61K 2800/5922 A61K 2800/621 A61K 2800/651

Filing Date

2025-10-03

Application No.

19349081

View original document →

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US20260096968A1

Who this affects

Applies to
Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent application IP registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Consumer Protection

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.